News
Launch of New Organ-on-Chip System
PR: Launch of New Organ-on-Chip SystemDownload
Read now
1st face-to-face meeting for EPIColiX project
👋 After the long pandemic, last week we could finally make it to Iceland to meet our colleagues at EpiEndo Pharmaceuticals face-to-face.The occasion was EPIColiX – a joint ground-breaking project aiming at developing a new gut-on-chip model for drug testing under the Eurostars program. ⚡️ We are very pleased about the achievements obtained so far...
Read now
The FDA Modernization Act 2.0 passed
🎉 Let’s start 2023 with good news: The FDA Modernization Act 2.0 has passed congress and is inked by President Biden! 🧫 This big achievement lets the FDA consider non-animal cutting-edge testing methods as standalone tests for preclinical studies, finally allowing the use Organs-on-Chip and NAMs for drug safety and efficacy assessment. 📑 𝘛𝘩𝘦 𝘍𝘋𝘈...
Read now
Aude Rapet won the ecopa Award at ESTIV 22
🏆 Congratulations to Aude Rapet for receiving the ecopa Award at the European Society of Toxicology in Vitro ESTIV Congress!!! We kindly thank the awarding committee, Costanza Rovida and Stefano Lorenzetti, for the recognition of this work, in which Aude presented the AXbreathing lung-on-chip use case in toxicology and drug testing with a focus on 3R and regulatory submission.   🙏 Thank you...
Read now
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Please find more information in our privacy policy

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

This website uses HubSpot to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.